Development of nanobiosensor for therapeutic drug monitoring in personalized cancer treatment approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of nanobiosensor for therapeutic drug monitoring in personalized cancer treatment approach

Published:2024-06-10 Issue:12 Volume:35 Page:1819-1844
ISSN:0920-5063
Container-title:Journal of Biomaterials Science, Polymer Edition
language:en
Short-container-title:Journal of Biomaterials Science, Polymer Edition

Author:

Kuru Cansu İlke¹²^ORCID,Sipahi Deniz¹^ORCID,Aydoğan Ceren¹^ORCID,Ulucan-Karnak Fulden²³^ORCID,Akgöl Sinan²⁴^ORCID

Affiliation:

1. Buca Municipality Buca Science and Art Center, Izmir, Turkey

2. Faculty of Science, Department of Biochemistry, Ege University, Izmir, Turkey

3. Health Science Institute, Department of Medical Biochemistry, Ege University, Izmir, Turkey

4. Nanotechnology Research and Application Center, Sabancı University, Istanbul, Turkey

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09205063.2024.2356965

Reference28 articles.

1. The rationale of dose–response curves in selecting cancer drug dosing

2. Cell Culture Based in vitro Test Systems for Anticancer Drug Screening

3. Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow

4. Farha NG, Kasi A. Docetaxel. Treasure Island (FL): StatPearls Publishing; 2022. https://europepmc.org/article/NBK/nbk537242.

5. Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP